PRNewswire
IRVING, Texas
(NASDAQ-OTCBB:RBCL)
IRVING, Texas, Jan. 12 /PRNewswire-FirstCall/ -- RBC Life Sciences
, a global provider of proprietary nutritional supplements, wound care
and pain management products, is offsetting 100 percent of its
electricity usage for two years as part of a company-wide green
initiative.
RBC
Life Sciences is purchasing 2,561,550 kilowatt hours of renewable
energy credits, which will help to avoid more than 3.4 million pounds
of carbon dioxide pollution. Over a two-year span, this commitment has
an impact comparable to planting more than 14,000 mature trees and
avoiding the pollution associated with driving 3.4 million miles in an
average car.
RBC
Life Sciences has also embarked on other energy-saving initiatives. The
company uses recycled paper as cushioning in product shipments, new
printer ink technology that will eliminate hundreds of pounds of used
printer cartridges and special lighting and printing technologies that
drastically reduce energy consumption.
"RBC
Life Sciences' commitment to sustainable energy meshes well with the
company's focus on providing nutritional supplements and skin care
products that highlight natural ingredients," said company President
and CEO John W. Price. "This company-wide commitment to reduce our
carbon footprint is part of a larger company effort to promote clean
energy projects and help America become less dependent on fossil fuels."
RBC
Life Sciences is purchasing the renewable energy credits from Renewable
Choice Energy, a Colorado-based company that works with the nation's
alternative energy sector. Every credit purchased helps fund new
renewable energy projects, such as wind farms.
About RBC Life SciencesRBC
Life Sciences develops, manufactures and markets high-quality
nutritional supplements and personal care products to a growing
population of consumers seeking wellness and a healthy lifestyle. Under
its MPM Medical Inc.
brand, RBC Life Sciences also develops and markets to health care
professionals in the United States proprietary prescription and
nonprescription products for advanced wound care and pain management.
All products are tested for quality assurance in-house, and by outside
independent laboratories, to comply with regulations in the U.S. and in
more than thirty countries in which the products are distributed. For
more information, visit the Company's Web site at www.rbclifesciences.com.
The
statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of
factors and risks including, but not limited to, changes in plans by
the Company's management, delays or problems in production, changes in
the regulatory process, changes in market trends, and a number of other
factors and risks described from time to time in the Company's filings
with the Securities and Exchange Commission.
SOURCE: RBC Life Sciences
Web site: http://www.rbclifesciences.com/